20/20 Biolabs, Inc.
IEX
Real-time Data
-
Day's Range
—52 wk Range
—Profile - AIDX - 20/20 Biolabs, Inc.
Profile
Mic Code
IEXG
Sector
Healthcare
Industry
Medical Devices
Employees
4
20/20 Biolabs, Inc. is a commercial-stage diagnostics company focused on AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases. The company’s core offerings include the OneTest family, which covers multi-cancer early detection testing and longevity-related biomarker analysis. It also operates CLIAx, a clinical laboratory innovation platform that supports diagnostic development and testing workflows for emerging health technology companies. 20/20 Biolabs serves the healthcare diagnostics market with products and services designed to improve clinical utility through machine learning and real-world data. Based in Gaithersburg, Maryland, the company plays a role in expanding access to advanced laboratory testing and supporting broader adoption of precision diagnostics.
Profile Details
Type
Common Stock
Ceo
Mr. Jonathan Cohen
Address
15810 Gaither Road
City
Gaithersburg
State
MD
Zip
20877
Country
United States
Phone
240 453 6339
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
